SI2704724T1 - Izboljšana formulacija suspenzije beklometazon dipropionata za dajanje z inhalacijo - Google Patents

Izboljšana formulacija suspenzije beklometazon dipropionata za dajanje z inhalacijo

Info

Publication number
SI2704724T1
SI2704724T1 SI201230800A SI201230800A SI2704724T1 SI 2704724 T1 SI2704724 T1 SI 2704724T1 SI 201230800 A SI201230800 A SI 201230800A SI 201230800 A SI201230800 A SI 201230800A SI 2704724 T1 SI2704724 T1 SI 2704724T1
Authority
SI
Slovenia
Prior art keywords
inhalation
administration
suspension formulation
improved suspension
beclometasone dipropionate
Prior art date
Application number
SI201230800A
Other languages
English (en)
Inventor
Anna Maria Cantarelli
Stefano Minari
Barbara Bassi
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44584766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2704724(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of SI2704724T1 publication Critical patent/SI2704724T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SI201230800A 2011-05-03 2012-04-18 Izboljšana formulacija suspenzije beklometazon dipropionata za dajanje z inhalacijo SI2704724T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11164575 2011-05-03
EP12719304.3A EP2704724B1 (en) 2011-05-03 2012-04-18 Improved suspension formulation of beclometasone dipropionate for administration by inhalation
PCT/EP2012/057068 WO2012150131A1 (en) 2011-05-03 2012-04-18 Improved suspension formulation of a corticosteroid for administration by inhalation

Publications (1)

Publication Number Publication Date
SI2704724T1 true SI2704724T1 (sl) 2017-01-31

Family

ID=44584766

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201230800A SI2704724T1 (sl) 2011-05-03 2012-04-18 Izboljšana formulacija suspenzije beklometazon dipropionata za dajanje z inhalacijo

Country Status (18)

Country Link
EP (2) EP2704724B1 (sl)
CN (1) CN103501791B (sl)
AR (1) AR086248A1 (sl)
BR (1) BR112013027391A2 (sl)
CY (1) CY1118315T1 (sl)
DK (1) DK2704724T3 (sl)
ES (1) ES2612257T3 (sl)
HR (1) HRP20161757T1 (sl)
HU (1) HUE030016T2 (sl)
LT (1) LT2704724T (sl)
ME (1) ME02586B (sl)
PL (1) PL2704724T3 (sl)
PT (1) PT2704724T (sl)
RS (1) RS55477B1 (sl)
RU (1) RU2611665C2 (sl)
SI (1) SI2704724T1 (sl)
WO (1) WO2012150131A1 (sl)
ZA (1) ZA201308158B (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103501791B (zh) 2011-05-03 2016-05-18 奇斯药制品公司 用于通过吸入给药的改良皮质类固醇悬浮制剂
CN107260665B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种吸入用糠酸莫米松混悬液组合物
CN107510687B (zh) * 2017-08-18 2020-07-03 南京海纳医药科技股份有限公司 一种供雾化用含有福莫特罗和布地奈德的吸入混悬液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
IT1303692B1 (it) 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
AU2003223477A1 (en) 2002-04-05 2003-10-27 University Of Utah Research Foundation Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
ITMI20020808A1 (it) 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
ITMI20022674A1 (it) 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
EP1454636A1 (en) 2003-03-04 2004-09-08 Dompé S.P.A. Sterilization of glucocorticoid drug particles for pulmonary delivery
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
GB0410995D0 (en) * 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
ITMI20051999A1 (it) * 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
US20090252801A1 (en) 2005-11-29 2009-10-08 Farmbios S.P.A. Process for the Preparation of Micronised Sterile Steroids
CA2707594C (en) * 2007-12-13 2015-08-18 Novartis Ag Process for preparing particulates of crystalline drug substance
CN103501791B (zh) 2011-05-03 2016-05-18 奇斯药制品公司 用于通过吸入给药的改良皮质类固醇悬浮制剂

Also Published As

Publication number Publication date
DK2704724T3 (en) 2017-01-09
LT2704724T (lt) 2017-01-10
HRP20161757T1 (hr) 2017-02-10
EP2704724B1 (en) 2016-10-26
CY1118315T1 (el) 2017-06-28
EP2704724A1 (en) 2014-03-12
EP3097915A1 (en) 2016-11-30
PL2704724T3 (pl) 2017-03-31
EP3097915B1 (en) 2024-01-24
ES2612257T3 (es) 2017-05-16
ZA201308158B (en) 2014-09-25
RS55477B1 (sr) 2017-04-28
RU2013148786A (ru) 2015-05-10
WO2012150131A1 (en) 2012-11-08
CN103501791A (zh) 2014-01-08
HUE030016T2 (en) 2017-04-28
CN103501791B (zh) 2016-05-18
ME02586B (me) 2017-06-20
AR086248A1 (es) 2013-11-27
BR112013027391A2 (pt) 2017-01-17
PT2704724T (pt) 2017-02-02
RU2611665C2 (ru) 2017-02-28

Similar Documents

Publication Publication Date Title
ZA201703992B (en) Inhalable pharmaceutical compositions
EP2720743A4 (en) MASK FOR THE ADMINISTRATION OF INHALED MEDICINE
IL230010B (en) Inhalable pharmaceutical ingredients
IL230881A0 (en) Preparations for pulmonary administration containing a eutectic mixture
HK1186737A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
PL2768479T3 (pl) Zaróbki do kompozycji terapeutycznych zawierających nikotynę
EP2661273A4 (en) IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION
IL228709A0 (en) Dosage unit form for oral administration
EP2747563A4 (en) COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS
SG11201400580VA (en) Pharmaceutical composition for inhalation
ZA201403195B (en) Pharmaceutical compositions of hydrophobic camptothecin derivatives
IL228182B (en) Pharmaceutical composition for administration of iloprost as aerosol bolus
PL2766008T3 (pl) Kompozycja do podawania donosowego o ulepszonej stabilności
ME02586B (me) Unapređena suspendovana formulacija beklometazon dipropionata za administraciju putem inhalacije
ZA201308905B (en) Nasal pharmaceutical formulation comprising fluticasone
ZA201401921B (en) Pharmaceutical composition of oxidised avidin suitable for inhalation
HK1190638A1 (zh) 用於犬呼吸道疾病綜合徵的組合物
HK1202451A1 (en) Therapeutic compositions for intranasal administration of zolpidem
IL237221A (en) Preparations containing analogues of phospholipid drugs
HUP1100561A2 (en) Cocrystals for producing pharmaceutical compositions
SG11201401570YA (en) Pharmaceutical compositions of resveratrol